XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Note 12 - Segment Data (Tables)

3 Months Ended

Jun. 30, 2024

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Three Months Ended June 30,
		2024				2023
Revenues (a):
Sterilization and Disinfection Control (b)		$	22,957			$	15,927
Clinical Genomics			11,404				13,369
Biopharmaceutical Development			12,008				9,889
Calibration Solutions			11,801				11,460
Total revenues		$	58,170			$	50,645
Gross profit:
Sterilization and Disinfection Control (b)		$	15,558			$	11,591
Clinical Genomics			6,490				6,728
Biopharmaceutical Development			7,959				6,433
Calibration Solutions			7,242				6,431
Gross profit		$	37,249			$	31,183
Reconciling items:
Operating expense			31,669				31,847
Operating income (loss)			5,580				(664	)
Nonoperating expense, net			1,675				273
Earnings (loss) before income taxes		$	3,905			$	(937	)

Schedule of Depreciation and Amortization Expense [Table Text Block]

		June 30,				March 31,
		2024				2024
Sterilization and Disinfection Control		$	6,465			$	7,014
Clinical Genomics			12,156				11,813
Biopharmaceutical Development			6,255				6,304
Calibration Solutions			6,891				7,544
Total inventories		$	31,767			$	32,675

X

- Definition

Tabular display of the depreciation and amortization recorded during the periods for reportable segments.

+ References

No definition available.

+ Details

Name:	mlab_ScheduleOfDepreciationAndAmortizationExpenseTableTextBlock
Namespace Prefix:	mlab_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration